DFSVX
Price
$62.16
Change
-$0.03 (-0.05%)
Updated
Jul 31 closing price
Net Assets
19.45B
ICSCX
Price
$36.69
Change
+$0.18 (+0.49%)
Updated
Jul 31 closing price
Net Assets
757.55M
Interact to see
Advertisement

DFSVX vs ICSCX

DFSVX vs ICSCX Comparison Chart in %
View a ticker or compare two or three
VS
DFSVX vs. ICSCX commentary
Aug 03, 2026

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is DFSVX is a StrongBuy and ICSCX is a Buy.

Interact to see
Advertisement
FUNDAMENTALS
Fundamentals
DFSVX has more cash in the bank: 19.5B vs. ICSCX (758M). DFSVX pays higher dividends than ICSCX: DFSVX (1.50) vs ICSCX (0.65). DFSVX was incepted earlier than ICSCX: DFSVX (33 years) vs ICSCX (37 years). ICSCX (0.93) is less costly to investors than DFSVX (0.31). ICSCX is a more actively managed with annual turnover of: 37.00 vs. DFSVX (7.00). DFSVX has a lower initial minimum investment than ICSCX: DFSVX (0) vs ICSCX (500000). DFSVX annual gain was more profitable for investors over the last year : 34.39 vs. ICSCX (32.01). DFSVX return over 5 years is better than : 50.66 vs. ICSCX (15.32).
DFSVXICSCXDFSVX / ICSCX
Total Expense Ratio0.310.8935%
Annual Report Gross Expense Ratio0.310.9333%
Fund Existence33 years37 years-
Gain YTD21.33623.12192%
Front LoadN/AN/A-
Min. Initial Investment0500000-
Min. Initial Investment IRAN/AN/A-
Net Assets19.5B758M2,573%
Annual Yield % from dividends1.500.65233%
Returns for 1 year34.3932.01107%
Returns for 3 years50.3725.94194%
Returns for 5 years50.6615.32331%
Returns for 10 years107.7141.68258%
View a ticker or compare two or three
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
HSVRX54.680.40
+0.74%
Harbor Small Cap Value Admin
DESSX29.040.10
+0.35%
DWS Enhanced Core Equity S
AGIRX22.310.05
+0.22%
Alger Mid Cap Growth Institutional R
IAXSX9.86-0.03
-0.30%
VY® T. Rowe Price Divers Mid Cap Gr S
THISX89.95-1.09
-1.20%
T. Rowe Price Health Sciences I